Miller Steve bought CPRX

August 27, 2025 · Form 4 insider transaction

Miller Steve bought 110,000 shares of Catalyst Pharmaceuticals Inc at $2.24 per share, a transaction worth $246.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
110,000
Price
$2.24
Total value
$246.4K
Role
SecurityCommon stock, par value $0.001 per share
Transaction codeM: Option exercise
Transaction dateAugust 27, 2025
Filing dateAugust 28, 2025
Shares owned after1,059,663
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR